PT1267899E - Vacinas de salmonella com ssa inactivados - Google Patents

Vacinas de salmonella com ssa inactivados

Info

Publication number
PT1267899E
PT1267899E PT01930419T PT01930419T PT1267899E PT 1267899 E PT1267899 E PT 1267899E PT 01930419 T PT01930419 T PT 01930419T PT 01930419 T PT01930419 T PT 01930419T PT 1267899 E PT1267899 E PT 1267899E
Authority
PT
Portugal
Prior art keywords
ssa
inactivated
salmonella vaccines
salmonella
vaccines
Prior art date
Application number
PT01930419T
Other languages
English (en)
Inventor
David E Lowery
Michael J Kennedy
Original Assignee
Pharmacia & Upjohn Co Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Co Llc filed Critical Pharmacia & Upjohn Co Llc
Publication of PT1267899E publication Critical patent/PT1267899E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/255—Salmonella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT01930419T 2000-03-17 2001-03-13 Vacinas de salmonella com ssa inactivados PT1267899E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19017800P 2000-03-17 2000-03-17

Publications (1)

Publication Number Publication Date
PT1267899E true PT1267899E (pt) 2005-11-30

Family

ID=22700305

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01930419T PT1267899E (pt) 2000-03-17 2001-03-13 Vacinas de salmonella com ssa inactivados

Country Status (17)

Country Link
US (2) US6923957B2 (pt)
EP (1) EP1267899B1 (pt)
JP (1) JP2003527433A (pt)
AR (1) AR027680A1 (pt)
AT (1) ATE300949T1 (pt)
AU (2) AU2001256957B2 (pt)
BR (1) BR0109322A (pt)
CA (1) CA2402252A1 (pt)
DE (1) DE60112413T2 (pt)
DK (1) DK1267899T3 (pt)
ES (1) ES2244617T3 (pt)
MX (1) MXPA02008748A (pt)
NZ (1) NZ521425A (pt)
PE (1) PE20011180A1 (pt)
PT (1) PT1267899E (pt)
WO (1) WO2001070247A2 (pt)
ZA (1) ZA200207002B (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE300949T1 (de) * 2000-03-17 2005-08-15 Pharmacia & Upjohn Co Llc Ssa inaktivierte salmonella impfstoffe
AU2004204751A1 (en) * 2003-01-09 2004-07-29 The Trustees Of The University Of Pennsylvania Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
CN1297315C (zh) * 2004-11-25 2007-01-31 上海交通大学 抗仔猪细菌性疫病复合卵黄抗体制剂的制备方法
CA2608636C (en) * 2005-05-17 2015-02-10 Frank Koentgen Sequential cloning system
US20070191736A1 (en) * 2005-10-04 2007-08-16 Don Alden Method for loading penetrating members in a collection device
CN101522210B (zh) 2006-09-18 2017-03-22 阿肯色大学评议会 增强免疫应答的组合物和方法
UA100370C2 (uk) * 2006-12-11 2012-12-25 Мериал Лимитед Спосіб вакцинації птахів проти salmonella
US20080260777A1 (en) * 2007-04-19 2008-10-23 Sotomayor Konky Composition and method for controlling intestinal pathogenic organisms
US7935355B2 (en) * 2007-04-19 2011-05-03 Nutritional Health Institute Laboratories, Llc Composition and method for controlling intestinal pathogenic organisms
NZ585776A (en) * 2007-10-30 2012-07-27 Univ Arkansas Compositions and methods of enhancing immune responses to flagellated bacterium
PL2214701T3 (pl) * 2007-11-01 2017-01-31 The Board Of Trustees Of The University Of Arkansas Kompozycje i sposoby wzmacniania odpowiedzi odpornościowych na Eimeria
CA2703621C (en) 2007-11-09 2022-03-22 The Salk Institute For Biological Studies Use of tam receptor inhibitors as antimicrobials
UA110024C2 (uk) 2010-01-21 2015-11-10 Вакцинний вектор і спосіб посилення імунної відповіді
KR102007132B1 (ko) 2010-06-09 2019-08-05 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 캄필로박터 감염을 감소시키기 위한 백신 및 방법
WO2012123269A1 (en) 2011-03-11 2012-09-20 Proyecto De Biomedicina Cima, S.L. Immunogenic compositions and methods for their use
US8481052B2 (en) 2011-05-17 2013-07-09 Cj Cheiljedang Corporation Avirulent Salmonella gallinarum variants and pharmaceutical composition using the same
US10548962B2 (en) 2012-10-22 2020-02-04 The Board Of Regents For Oklahoma State University Use of the salmonella SPP type III secretion proteins as a protective vaccination
US20150238590A1 (en) * 2012-10-22 2015-08-27 The Board Of Regents For Oklahoma State University Use of the salmonella spp type iii secretion proteins as a protective vaccination
US9950053B2 (en) 2012-10-22 2018-04-24 The Board Of Regents For Oklahoma State University Use of the Salmonella SPP type III secretion proteins as a protective vaccination
NZ711019A (en) 2013-02-14 2019-07-26 Univ Arkansas Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection
EP2968423A4 (en) 2013-03-15 2016-11-09 Univ Arkansas COMPOSITIONS AND METHODS FOR INCREASING IMMUNE REACTIONS AGAINST ENTERAL PATHOGENES
US20170333493A1 (en) * 2014-11-11 2017-11-23 Ohio State Innovation Foundation Probiotic bacteria for the prevention and treatment of salmonella
AU2016323106A1 (en) * 2015-09-16 2018-03-29 Boehringer Ingelheim Animal Health USA Inc. Salmonella Choleraesuis-Salmonella Typhimurium vaccines
BR112018072592A2 (pt) 2016-05-03 2019-04-16 The Board Of Trustees Of The University Of Arkansas vetor de vacina de levedura que inclui polipeptídeos imunoestimulantes e antigênicos, e métodos de uso dos mesmos

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8205892D0 (sv) 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US4877612A (en) 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
ES2039229T3 (es) 1986-01-14 1993-09-16 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezondheid En Cultuur Procedimiento para la preparacion de complejos inmunogenicos y composiciones farmaceuticas que contienen estos complejos.
US4806352A (en) 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
RU2370541C2 (ru) 1994-12-09 2009-10-20 Имерджент Продакт Дивелопмент Юк Лимитед Vgc2 днк salmonella typhimurium, мутантная бактерия, обладающая пониженной способностью к адаптации к условиям окружающей среды, и способ ее получения
EP1108034B1 (en) * 1998-09-04 2008-08-06 Emergent Product Development UK Limited Attenuated salmonella spi2 mutants as antigen carriers
NZ519477A (en) 1999-12-23 2004-04-30 Microscience Ltd Attenuated microorganisms for the treatment of infection
ATE300949T1 (de) * 2000-03-17 2005-08-15 Pharmacia & Upjohn Co Llc Ssa inaktivierte salmonella impfstoffe

Also Published As

Publication number Publication date
MXPA02008748A (es) 2003-02-24
EP1267899A2 (en) 2003-01-02
US6923957B2 (en) 2005-08-02
US20040009191A1 (en) 2004-01-15
ES2244617T3 (es) 2005-12-16
NZ521425A (en) 2004-05-28
PE20011180A1 (es) 2001-11-15
ATE300949T1 (de) 2005-08-15
AU2001256957B2 (en) 2005-08-25
WO2001070247A3 (en) 2002-04-18
AU5695701A (en) 2001-10-03
US20050260223A1 (en) 2005-11-24
ZA200207002B (en) 2004-03-31
DE60112413T2 (de) 2006-06-01
DE60112413D1 (de) 2005-09-08
BR0109322A (pt) 2002-12-10
WO2001070247A2 (en) 2001-09-27
EP1267899B1 (en) 2005-08-03
DK1267899T3 (da) 2005-12-12
JP2003527433A (ja) 2003-09-16
CA2402252A1 (en) 2001-09-27
AR027680A1 (es) 2003-04-09

Similar Documents

Publication Publication Date Title
PT1267899E (pt) Vacinas de salmonella com ssa inactivados
DE60135542D1 (de) Echanischem verschluss
NO20031483D0 (no) Vaksine
NO20014325L (no) Vaksine
NO20030823L (no) Vaksiner
NO20021433L (no) Vaksiner
NO20024172D0 (no) Vaksine
NO20031705D0 (no) Vaksiner
BR0111116B1 (pt) Imitadores de trombopoietina
DE60118266D1 (de) Kochgerät
NO20006191D0 (no) Vaksine
DE50106783D1 (de) Sensoranordnung
DE60002650D1 (de) Öladjuvierter Impfstoff
NO20020763D0 (no) Vaksine
DE60124721D1 (de) Federsensoranordnungen
NO20032745L (no) Et forbedret varmeapparat
DE69938555D1 (de) Impfstoff gegen geschlechtlich übertragene krankheiten
DE60105903D1 (de) Kochgerät
DE60105902D1 (de) Kochgerät
DE60103462D1 (de) Kochgerät
DE50105483D1 (de) Feuerstätte
FI20002308A0 (fi) Saunan kiuas
ES1045956Y (es) Dispositivo de identificacion de alimentos.
FIU990120U0 (fi) Monienergiakattila
ITBA20010050A0 (it) Arpione